Artiva Biotherapeutics, Inc. (ARTV) stock
ARTVNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.77−0.09 (-2.33%)
Close on Nov 18, 2026Market cap $184.32MP/E –Yield –
Artiva Biotherapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Artiva Biotherapeutics's price to sales ratio was 10.4× on Jan 31, 2025.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jan 31, 2025 | 10.4× | −10.3 |
| 2024 | Dec 31, 2024 | 20.7× | – |
See a number that looks wrong?